Overview
- Includes supplementary material: sn.pub/extras
Part of the book series: Ethics of Science and Technology Assessment (ETHICSSCI, volume 35)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (9 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
Recent scientific advances have made it possible to produce biopharmaceuticals in genetically modified plants and animals, such as maize, tobacco, goats, and chickens. This new branch of biotechnology is termed pharming, composed of the terms pharmaceuticals and farming. Pharming constitutes an overlap of red and green biotechnology. It offers the prospect of a quicker, cheaper, and more flexible production of biopharmaceuticals compared with current production processes. This is a promising perspective in light of the rapidly growing market of biopharmaceuticals, although the economic competitiveness of pharming remains to be proven. Besides possible benefits for producers, patients and health care systems, pharming also raises a number of complex ecological, social, moral and legal questions that have as yet not been thoroughly discussed.
The present book contains the findings of an interdisciplinary research project that has addressed a large range of questions associated with pharming: An analysis of the state-of-the-art of plant pharming and animal pharming technologies is followed by an assessment of environmental risks related to pharming and welfare risks for pharming animals. Public views and attitudes to pharming are investigated on the basis of a comprehensive survey in 15 countries. Moreover, ethical and legal questions, posed by present and foreseeable future practices of pharming, are analysed. The concluding chapter presents the authors’ main findings and recommendations, addressed to science, industry, politics and general public interested in the chances and risks of this upcoming field of biotechnology.
Authors and Affiliations
Bibliographic Information
Book Title: Pharming
Book Subtitle: Promises and risks ofbBiopharmaceuticals derived from genetically modified plants and animals
Authors: Eckard Rehbinder, E. Rehbinder, M. Engelhard, K. Hagen, R. B. Jørgensen, R. Pardo-Avellaneda, A. Schnieke, … F. Thiele
Series Title: Ethics of Science and Technology Assessment
DOI: https://doi.org/10.1007/978-3-540-85793-8
Publisher: Springer Berlin, Heidelberg
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer-Verlag Berlin Heidelberg 2009
Hardcover ISBN: 978-3-540-85792-1Published: 17 October 2008
Softcover ISBN: 978-3-642-09935-9Published: 10 November 2010
eBook ISBN: 978-3-540-85793-8Published: 27 September 2008
Series ISSN: 1860-4803
Series E-ISSN: 1860-4811
Edition Number: 1
Number of Pages: XX, 334
Topics: Pharmacology/Toxicology, Biochemical Engineering, Ethics, Biomedical Engineering and Bioengineering